Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative Diseases
KLS-1(64锌天冬氨酸盐)在癌症和神经退行性疾病患者中的首次人体剂量递增和剂量扩展研究(I期)
期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.29921
Perez, Jesus A; Lopez, Javier J; Torres Badillo, Claudia C; Gill, Jaya; Kesari, Santosh; Novak, Peter; Temnikov, Max; Byshovets, Roman; Bychkov, Oleg